BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7371859)

  • 21. Propylthiouracil, a selective inhibitor of NADH-cytochrome b5 reductase.
    Lee E; Kariya K
    FEBS Lett; 1986 Dec; 209(1):49-51. PubMed ID: 3803575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractionation of liver microsomes with polyethylene glycol and purification of NADH-cytochrome b5 oxidoreductase and cytochrome b5.
    Yang MX; Cederbaum AI
    Arch Biochem Biophys; 1994 Dec; 315(2):438-44. PubMed ID: 7986089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of the integral membrane protein NADH-cytochrome b5 reductase in rat liver cells, studied with a quantitative radioimmunoblotting assay.
    Borgese N; Pietrini G
    Biochem J; 1986 Oct; 239(2):393-403. PubMed ID: 3814080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization, biosynthesis, and turnover of NADH-cytochrome b5 reductase, a protein that exists in a membrane-bound and a water-soluble form.
    Borgese N
    Prog Clin Biol Res; 1982; 91():479-93. PubMed ID: 7146010
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification and properties of a membrane-bound NADH-cytochrome-b5 reductase from erythrocytes of the sipunculid worm, Phascolopsis gouldii.
    Bonomi F; Long RC; Kurtz DM
    Biochim Biophys Acta; 1989 Nov; 999(2):147-56. PubMed ID: 2597703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and partial characterization of the NH2-terminal membrane-binding domain of NADH-cytochrome b5 reductase.
    Kensil CR; Hediger MA; Ozols J; Strittmatter P
    J Biol Chem; 1983 Dec; 258(23):14656-63. PubMed ID: 6643503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and partial characterization of microsomal NADH-cytochrome b5 reductase from higher plant Catharanthus roseus.
    Madyastha KM; Chary NK; Holla R; Karegowdar TB
    Biochem Biophys Res Commun; 1993 Dec; 197(2):518-22. PubMed ID: 8267585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The molecular weight of NADPH-cytochrome C reductase isolated by immunoprecipitation from detergent-solubilized rat liver microsomes.
    Welton AF; Pederson TC; Buege JA; Aust SD
    Biochem Biophys Res Commun; 1973 Sep; 54(1):161-7. PubMed ID: 4354940
    [No Abstract]   [Full Text] [Related]  

  • 29. Biodiversity of the P450 catalytic cycle: yeast cytochrome b5/NADH cytochrome b5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction.
    Lamb DC; Kelly DE; Manning NJ; Kaderbhai MA; Kelly SL
    FEBS Lett; 1999 Dec; 462(3):283-8. PubMed ID: 10622712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrostatic properties deduced from refined structures of NADH-cytochrome b5 reductase and the other flavin-dependent reductases: pyridine nucleotide-binding and interaction with an electron-transfer partner.
    Nishida H; Miki K
    Proteins; 1996 Sep; 26(1):32-41. PubMed ID: 8880927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CMP-N-acetylneuraminic acid hydroxylase from mouse liver and pig submandibular glands. Interaction with membrane-bound and soluble cytochrome b5-dependent electron transport chains.
    Shaw L; Schneckenburger P; Schlenzka W; Carlsen J; Christiansen K; Jürgensen D; Schauer R
    Eur J Biochem; 1994 Feb; 219(3):1001-11. PubMed ID: 8112313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of NADH-cytochrome b5 reductase during dimethyl sulfoxide-induced differentiation of Friend erythroleukemia cells.
    Lostanlen D; Kaplan JC
    FEBS Lett; 1982 Jun; 143(1):35-9. PubMed ID: 7117520
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterogeneity of the rat NADH-cytochrome-b5-reductase transcripts resulting from multiple alternative first exons.
    Mota Vieira L; Kaplan JC; Kahn A; Leroux A
    Eur J Biochem; 1994 Mar; 220(3):729-37. PubMed ID: 8143727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural analysis of NADH-cytochrome b5 reductase in relation to hereditary methemoglobinemia.
    Yubisui T; Murakami K; Shirabe K; Takeshita M; Zenno S; Tomatsu S; Fukumaki Y
    Prog Clin Biol Res; 1989; 319():107-19; discussion 120-1. PubMed ID: 2695933
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of alternative first exons of NADH-cytochrome b5 reductase gene expressed ubiquitously in human cells.
    Du M; Shirabe K; Takeshita M
    Biochem Biophys Res Commun; 1997 Jun; 235(3):779-83. PubMed ID: 9207238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The binding of cytochrome b5 to plasma membranes of rat liver: its implication for membrane specificity and biogenesis.
    Remacle J
    Biochim Biophys Acta; 1980 Apr; 597(3):564-76. PubMed ID: 7378403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological similarity between NADH-cytochrome b5 reductase of erythrocytes and liver microsomes.
    Goto-Tamura R; Takesue Y; Takesue S
    Biochim Biophys Acta; 1976 Feb; 423(2):293-302. PubMed ID: 2319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitory effect of halides and carboxylates on hepatic NADH: cytochrome b5 oxidoreductase.
    Tamura M; Yubisui T; Takeshita M
    Biochem J; 1985 Aug; 230(1):273-6. PubMed ID: 4052043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The NH2-terminal structures of human and rat liver microsomal NADH-cytochrome b5 reductases.
    Murakami K; Yubisui T; Takeshita M; Miyata T
    J Biochem; 1989 Feb; 105(2):312-7. PubMed ID: 2498303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian changes of cytochrome P-450-dependent monooxygenase system in the rat liver.
    Plewka A; Czekaj P; Kamiński M; Plewka D
    Pol J Pharmacol Pharm; 1992; 44(6):655-61. PubMed ID: 1305961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.